Health - Latest News Search Engine - Global and Local Breaking News

Health

Meala Partners with dsm-firmenich to Commercialize Texturizing Protein for Meat Alternatives

VertisTM PB Pea protein, a high-performance texturizer is ready for market release in Europe, bringing cleaner labels and better nutritional value to ...

Meala Partners with dsm-firmenich to Commercialize Texturizing Protein for Meat Alternatives

Genprex to Participate at BIO 2025 International Convention

AUSTIN, Texas, June 3, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused o...

Genprex to Participate at BIO 2025 International Convention

Centurion Health Champions Compassionate Care in Correctional Facilities

Delivering Comprehensive Healthcare to Change Lives and Communities STERLING, Va., June 3, 2025 /PRNewswire/ -- Centurion Health, a leader in correcti...

Centurion Health Champions Compassionate Care in Correctional Facilities

EnableComp Welcomes New Chief Technology Officer

Brian Kenah brings decades of proven experience delivering client value through innovative healthcare technology and operational leadership FRANKLIN, ...

EnableComp Welcomes New Chief Technology Officer

New Partnership: UE Systems & perma Launch Groundbreaking Lubrication Technology

CHARLOTTE, N.C., June 3, 2025 /PRNewswire/ --perma, the global leader in single-point lubrication systems, has joined forces with UE Systems, the worl...

New Partnership: UE Systems & perma Launch Groundbreaking Lubrication Technology

Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology

VALIANT Phase 3 data in nephrology after presentation at the ERA congress. STOCKHOLM, June 3, 2025 /PRNewswire/ -- Investors, analysts, and members of...

Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-base...

This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional br...

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression

New Multicenter Study Demonstrates SyMRI's Potential to Transform Clinical Neuroimaging Workflows

LINKÖPING, Sweden, June 3, 2025 /PRNewswire/ -- SyntheticMR AB (publ) is proud to share the results of a newly published multicenter clinical study in...

New Multicenter Study Demonstrates SyMRI's Potential to Transform Clinical Neuroimaging Workflows

Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing

Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies BOSTON, June 3, 2025 /...

Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing

Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy

Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists Prof Ignacio Melero and Prof...

Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy

Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System

- One-year follow-up data from first-in-human trial shows significant improvements in key clinical performance outcomes - This data supports a strong ...

Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System

CareLineLive Secures Majority Investment from Technology Investment Firm Accel-KKR

LONDON and MENLO PARK, Calif., June 3, 2025 /PRNewswire/ -- CareLineLive, an all-in-one home care management software company, has secured a majority ...

CareLineLive Secures Majority Investment from Technology Investment Firm Accel-KKR

Désengorger les urgences en France devient plus simple : LGI Réorientation disponible via le catalogue de l'UGAP.

MONTRÉAL, le 3 juin 2025 /PRNewswire/ -- LGI Solutions Santé, un leader québécois en technologies de la santé reconnu à l'international, est ravi d'an...

Désengorger les urgences en France devient plus simple : LGI Réorientation disponible via le catalogue de l'UGAP.

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 ...

EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6...

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

AmphiStar and Kensing Announce Strategic Partnership to Bring Upcycled Biosurfactants to the North American Personal Care Market

Partnership delivers localized access to 100% upcycled biosurfactants with significantly reduced environmental impact, while advancing novel designer ...

AmphiStar and Kensing Announce Strategic Partnership to Bring Upcycled Biosurfactants to the North American Personal Care Market

NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING

HOUSTON, June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare deliv...

NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING

Erweiterung eines Vermächtnisses im Bereich Schlaganfall: Terumo Neuro gibt die kommerzielle Verfügbarkeit des SOFIA™ Flow 88 Neurovaskulären Aspirati...

Die SOFIA ™ --Katheterreihe von Terumo Neuro basiert auf 10 Jahren bewährter klinischer Leistung1-9 und Innovation - der neue SOFIA™ Flow 88 bietet zu...

Erweiterung eines Vermächtnisses im Bereich Schlaganfall: Terumo Neuro gibt die kommerzielle Verfügbarkeit des SOFIA™ Flow 88 Neurovaskulären Aspirationskatheters in EMEA bekannt

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients...

SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical com...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovaria...

SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical com...

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors

2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gas...

YANTAI, China, June 2, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beiji...

2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer